InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,186.33
(
-3.00%
)
US TECH 100
17,570.00
(
0.89%
)
Dow Jones
38,703.27
(
-2.60%
)
Brent Oil
76.35
(
-1.06%
)
Bitcoin
54,904.30
(
1.72%
)
Post# of 252790
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120214
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 131897

Friday, 12/02/2011 1:42:33 PM

Friday, December 02, 2011 1:42:33 PM

Post# of 252790
Teva’s Lipitor was evidently just a backup plan for Ranbaxy, and Ohm Laboratories of NJ is the manufacturer of Ranbaxy’s Lipitor. However, Teva is nonetheless getting a cut of Ranbaxy’s sales.

http://www.bloomberg.com/news/2011-12-02/ranbaxy-falls-after-teva-says-it-won-t-supply-lipitor-ingredient.html

Nice gig for Teva! It’s like financiers who get a “standby” fee even if their credit line is never tapped.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up